CK Life Sciences Intl (Holdings) Inc
HKEX:775
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.31
0.71
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
CK Life Sciences Intl (Holdings) Inc
CK Life Sciences Intl (Holdings) Inc
Cash & Cash Equivalents
CK Life Sciences Intl (Holdings) Inc
Cash & Cash Equivalents Peer Comparison
690
1061
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
CK Life Sciences Intl (Holdings) Inc
HKEX:775
|
Cash & Cash Equivalents
HK$549.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
H
|
Hbm Holdings Ltd
HKEX:2142
|
Cash & Cash Equivalents
$140.3m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
C
|
China Regenerative Medicine International Ltd
HKEX:8158
|
Cash & Cash Equivalents
HK$3.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Uni-Bio Science Group Ltd
HKEX:690
|
Cash & Cash Equivalents
HK$154m
|
CAGR 3-Years
17%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Essex Bio-Technology Ltd
HKEX:1061
|
Cash & Cash Equivalents
HK$598.4m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
See Also
What is CK Life Sciences Intl (Holdings) Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
549.2m
HKD
Based on the financial report for Jun 30, 2024, CK Life Sciences Intl (Holdings) Inc's Cash & Cash Equivalents amounts to 549.2m HKD.
What is CK Life Sciences Intl (Holdings) Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-4%
Over the last year, the Cash & Cash Equivalents growth was 11%. The average annual Cash & Cash Equivalents growth rates for CK Life Sciences Intl (Holdings) Inc have been -7% over the past three years , -4% over the past five years .
You don't have any saved screeners yet
